Aesthetic Medical International Holdings Group Limited (FRA:3FMA)
Germany flag Germany · Delayed Price · Currency is EUR
0.0090
0.00 (0.00%)
Last updated: May 21, 2026, 9:55 AM CET

FRA:3FMA Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-53.35-19.95-37.43-76.25-586.62
Depreciation & Amortization
58.5865.6265.961.4999.14
Other Amortization
0.310.35--3.96
Loss (Gain) From Sale of Assets
12.626.178.0331.837.26
Asset Writedown & Restructuring Costs
0.53-12.150.15-310
Loss (Gain) From Sale of Investments
--0.222.92-
Loss (Gain) on Equity Investments
-----0.08
Stock-Based Compensation
--7.5127.5335.46
Other Operating Activities
28.9828.21-23.5529.43-65.86
Change in Accounts Receivable
1.61.12-3.971.33.85
Change in Inventory
-3.980.6712.27-0.29-0.8
Change in Accounts Payable
-12.195.9728.0216.394.54
Change in Unearned Revenue
-7.420.8923.33-66.73228.15
Change in Other Net Operating Assets
-37.922.78-6.2-102.72-17.91
Operating Cash Flow
-12.2379.6774.29-75.1351.09
Operating Cash Flow Growth
-7.25%---

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-6.9-30.6-55.24-1.6-33.24
Sale of Property, Plant & Equipment
6.560.070.01-0.17
Cash Acquisitions
----0.64-7.27
Divestitures
--00.789.51-1.35
Sale (Purchase) of Intangibles
-0.08-0.19-0.22-0.08-0.21
Investment in Securities
--0.08--
Other Investing Activities
0.140.42.34-4.0830.38
Investing Cash Flow
-0.28-30.32-52.253.11-11.53

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
163.23159.0998.71276.31240.9
Long-Term Debt Repaid
-123.75-218.2-228.96-310.06-272.19
Net Debt Issued (Repaid)
39.48-59.11-130.25-33.75-31.29
Issuance of Common Stock
--17094.15-
Other Financing Activities
-9.55-9.44-10.69-14.86-13.94
Financing Cash Flow
29.93-68.5529.0645.55-45.24

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
--0.3-0.93-0.670.57
Net Cash Flow
17.42-19.550.18-27.13-5.1

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-19.1349.0719.04-76.7217.85
Free Cash Flow Growth
-157.69%---
Free Cash Flow Margin
-2.65%6.49%2.79%-11.45%2.77%
Free Cash Flow Per Share
-0.401.030.43-2.810.81
Levered Free Cash Flow
9.8343.49-6.1415.2146.6
Unlevered Free Cash Flow
15.2948.942.9128.72163.62

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
8.758.7210.1514.6112.83
Cash Income Tax Paid
1.410.520.020.630.62
Change in Working Capital
-59.911.4353.46-152.04217.84